现代中药集团(01643)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01643 现代中药集团

已收盘 11-10 16:08:34

0.355

-0.005

-1.39%

最高0.360	最低0.335	成交量79.20万
今开0.340	昨收0.360	日振幅6.94%
总市值2.56亿	流通市值2.56亿	总股本7.20亿
成交额27.44万	换手率0.11%	流通股本7.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01643","market":"HK","secType":"STK","nameCN":"现代中药集团","latestPrice":0.355,"timestamp":1794298114417,"preClose":0.36,"halted":0,"volume":792000,"delay":0,"changeRate":-0.013888888888888902,"floatShares":720000000,"shares":720000000,"eps":-0.0205,"marketStatus":"已收盘","change":-0.005,"latestTime":"11-10 16:08:34","open":0.34,"high":0.36,"low":0.335,"amount":274440,"amplitude":0.069444,"askPrice":0.365,"askSize":6000,"bidPrice":0.355,"bidSize":81000,"shortable":0,"etf":0,"ttmEps":-0.067186,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794360600000},"marketStatusCode":5,"adr":0,"listingDate":1610640000000,"exchange":"SEHK","adjPreClose":0.36,"openAndCloseTimeList":[[1794274200000,1794283200000],[1794286800000,1794297600000]],"volumeRatio":1.554404,"lotSize":3000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01643","defaultTab":"news","newsList":[{"id":"1181442362","title":"现代中药集团10月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1181442362","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181442362?lang=zh_cn&edition=full","pubTime":"2026-11-02 16:39","pubTimestamp":1793608760,"startTime":"0","endTime":"0","summary":"现代中药集团有限公司于2026年11月2日披露2026年10月股份变动月报表。公告显示，截至2026年10月31日，公司法定股本总额维持在港币100,000,000元，股份数目10,000,000,000股，单股面值为港币0.01元。\n同期已发行普通股合计720,000,000股，与上月末持平，未见任何新增发行、购回、注销或库藏股变动。公告内容同时显示，公司股本规模整体保持稳定。\n报告期内，现代中药集团已满足香港联交所对公众持股量的规定。公告由执行董事张宏丽签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677481109","title":"ESMO年会开幕，创新药快速拉升，恒生生物科技指数翻红","url":"https://stock-news.laohu8.com/highlight/detail?id=2677481109","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677481109?lang=zh_cn&edition=full","pubTime":"2026-10-23 13:56","pubTimestamp":1792734960,"startTime":"0","endTime":"0","summary":"10月23日午后，港股三大指数集体拉升，恒生科技指数一度涨超2%，恒生国企指数、恒生指数跟涨；恒生生物科技指数午后翻红，亚盛医药、翰森制药、科伦博泰生物、先声药业、康方生物等盘中涨幅 ...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261023/c681018111.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261023/c681018111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1574","MEDX","03347","03613","06127","02273","03737","09926","02269","06978","06606","01666","BK1161","LNGR","IBBQ","03759","01643","159992","00570","06160","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123306024","title":"现代中药集团（01643）终止合约安排并收购承德御室金丹药业全部股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1123306024","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123306024?lang=zh_cn&edition=full","pubTime":"2026-10-21 17:55","pubTimestamp":1792576539,"startTime":"0","endTime":"0","summary":"现代中药集团有限公司10月21日公告称，已与合约安排订约各方达成协议：由孙新磊女士向公司全资附属公司石家庄药研咨询有限公司转让其所持有的承德御室金丹药业有限公司全部股权；同步解除现行合约安排。截至本公告日，现代中药集团董事会由三名执行董事孙新磊女士、张宏丽女士及贾艳茹女士，以及三名独立非执行董事刘凌女士、梁子荣先生和黄志坚先生组成。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675455167","title":"【券商聚焦】中信证券：市场风格趋于谨慎 中药高股息标的关注度持续上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2675455167","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675455167?lang=zh_cn&edition=full","pubTime":"2026-10-16 08:52","pubTimestamp":1792111979,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券表示，近期，市场风格趋于谨慎，中药高股息标的关注度持续上升。在此背景下，中药板块凭借\"低估值+高股息+成本端改善\"三重属性，成为具备高确定性的细分投资板块。该机构梳理两条投资主线：1）高股息率、业绩稳健标的。2）业绩边际向好、股息率具备一定吸引力的标的。风险因素：渠道库存积压的风险；业绩不及预期的风险；成本上涨的风险；集采不及预期的风险；重大支出后降低股息率的风险。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993818","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK1191","00874","EASY","ABEQ","03613","02161","LU1720050803.USD","PY","02877","PRIZ","LU1794554557.SGD","BK1219","LU2148510915.USD","BK1570","00570","LU1064130708.USD","LU1255011170.USD","02273","CGVV","159207","BK1197","KCE","01643","LU1064131003.USD","LU1146622755.USD","LU1580142542.USD","BK0188","BK1521","06030","LU0405327494.USD","BK1515","BK0012","LU1328615791.USD","LU2580892862.HKD","LU0405327148.USD","LU1997244956.HKD","QUSA","03320","BK0276","BK1516","LU1820825898.SGD","BK1564","LU1781817850.SGD","FTDS","LU2580892789.USD","600030","LU2289578879.USD","BK0196","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196640485","title":"现代中药集团9月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1196640485","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196640485?lang=zh_cn&edition=full","pubTime":"2026-10-02 16:47","pubTimestamp":1790930853,"startTime":"0","endTime":"0","summary":"现代中药集团于2026年10月2日发布2026年9月股份变动月报表，报告期为2026年9月1日至9月30日。公告显示，截至报告期末，公司的法定注册股本维持在10,000,000,000股，每股面值港币0.01元，总计港币100,000,000元；已发行股份总数则与上月一致，保持在720,000,000股，无新增发行、购回、注销或库藏股变动。同时，公告披露公司并未在本期内执行任何股份期权、认股权证或可换股票据，也无其他影响已发行股份或库存股份数量的法律协议或安排。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138927726","title":"现代中药集团2026年上半年财报：营收1.19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138927726","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138927726?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:23","pubTimestamp":1790587387,"startTime":"0","endTime":"0","summary":"根据公司公告，现代中药集团在2026年上半年实现营收约1.19亿元，同比上期的64.8百万元增长约82.9%。同期，公司毛利由16.2百万元上升至22.1百万元，增幅约36.4%。毛利率由上期的25.0%下降至18.7%。研发投入方面，本期相应费用约15.3百万元。报告期内，销售网络覆盖中国约50座城市，由95名经销商组成。其中，中国东北地区依然是最大营收贡献地区，本报告期对总收益贡献比例超过50%，较上期的43.5%进一步提高。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"现代中药集团2026年上半年财报：营收1.19亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148036603","title":"现代中药集团8月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1148036603","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148036603?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:41","pubTimestamp":1788424876,"startTime":"0","endTime":"0","summary":"现代中药集团有限公司于2026年9月3日发布2026年8月31日止月份的股份变动月报表。报告显示，截至8月底，公司法定股本总额依然为港币100,000,000，注册股份数目为10,000,000,000股，面值为每股港币0.01，较上月底保持不变。本次月报由公司执行董事张宏丽签署，现代中药集团有限公司表示将继续严格遵守香港联合交易所有限公司《上市规则》及其他适用法律法规，确保信息披露的及时、准确和完整。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662972091","title":"现代中药集团(01643.HK)公布中期业绩 公司拥有人应占亏损2590万元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2662972091","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662972091?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:40","pubTimestamp":1787928029,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1606","01643","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153923493","title":"现代中药集团2026年中期财报：营收1.19亿元，同比增长82.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153923493","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153923493?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:20","pubTimestamp":1787923205,"startTime":"0","endTime":"0","summary":"根据公告，现代中药集团截至2026年6月30日止六个月收入约为118.5百万元，较上年同期的64.8百万元大幅增长82.9%。同期毛利由16.2百万元提升至22.1百万元，同比增长36.4%，毛利率约18.7%。经营活动所用现金净额为48.5百万元，而上年同期为现金净流入63.5百万元。报告期内，销售及分销开支、行政及其他经营开支以及研发开支均有所上升，其中研发投入约15.28百万元，占收入约12.9%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"现代中药集团2026年中期财报：营收1.19亿元，同比增长82.9%","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661129849","title":"现代中药集团(01643)发盈警 预期中期取得净亏损约2590万元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2661129849","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661129849?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:40","pubTimestamp":1787316023,"startTime":"0","endTime":"0","summary":"智通财经APP讯，现代中药集团(01643)发布公告，基于对本集团截至2026年6月30日止6个月(本期间)的未经审核综合管理账目及董事会目前可得资料作出的初步评估，预期本集团将于本期间取得净亏损约人民币2590万元，而截至2025年6月30日止年度则取得约人民币250万元的净溢利。据董事所深知，由净溢利转为净亏损乃主要归因于1)为配合扩展中国华东地区业务，导致推广及市场费用增加;及2)为提高产品质量，及提升和临床价值研究，导致研发成本增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"现代中药集团(01643)发盈警 预期中期取得净亏损约2590万元 同比盈转亏","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01643","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131236227","title":"现代中药集团(01643)发布盈利预警：截至2026年6月30日录得约人民币25.9百万元净亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=1131236227","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131236227?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:16","pubTimestamp":1787314560,"startTime":"0","endTime":"0","summary":"现代中药集团有限公司（01643）8月21日发布盈利预警，董事会基于截至2026年6月30日止六个月的未经审计综合管理账目及现有资料的初步评估，预计本期间将录得约人民币25.9百万元的净亏损；而截至2025年6月30日止年度则实现约人民币2.5百万元的净溢利，显示业绩由盈转亏。\n公司指出，亏损主要由于两方面原因：一是为配合在中国华东地区的业务扩展，推广及市场费用增加；二是为提高产品质量及推进临床价值研究，研发成本上升。\n上述数据尚未经独立核数师审核或公司审核委员会审阅，相关信息可能有所调整。公司预计将于2026年8月28日披露中期业绩，提醒股东及潜在投资者在买卖公司证券时保持审慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108679029","title":"现代中药集团中期净亏损 主要源于推广、营销及研发费用增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1108679029","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108679029?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:08","pubTimestamp":1787314093,"startTime":"0","endTime":"0","summary":"现代中药集团近期公布的中期业绩显示，公司出现净亏损。究其原因，主要归咎于推广活动、市场营销以及研发投入等方面开支的显著攀升。据悉，该集团在报告期内的支出结构发生了明显变化，尤其是在品牌推广、市场拓展以及新产品研发等关键领域，资金投入力度大幅增强。分析人士指出，现代中药集团此举或意在夯实市场基础、加速产品管线布局，但成本端的集中释放无疑给当期盈利带来了不小挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1191","01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176484858","title":"现代中药集团(01643)拟于8月28日召开董事会 审议2026年中期业绩及股息方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1176484858","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176484858?lang=zh_cn&edition=full","pubTime":"2026-08-13 19:01","pubTimestamp":1786618876,"startTime":"0","endTime":"0","summary":"现代中药集团有限公司(01643)8月13日公告，公司董事会将于2026年8月28日(星期五)召开会议。届时，董事会将审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩，以及该业绩公告的发布事宜，并同时考虑派发中期股息的建议(如有)。\n公告显示，现任董事会由三名执行董事和三名独立非执行董事组成。执行董事为孙新磊、张宏丽及贾艳茹；独立非执行董事为刘凌、梁子荣及黄志坚。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143010357","title":"现代中药集团7月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1143010357","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143010357?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:50","pubTimestamp":1785747005,"startTime":"0","endTime":"0","summary":"现代中药集团（股票代码：01643）于2026年8月3日披露截至2026年7月31日止的证券变动月报表。报告期内，公司未有新增股份发行、购回或库藏股变动，股本维持不变。\n根据公告，截至2026年7月31日，现代中药集团的法定/注册股本总额为港币100,000,000元，与上月底保持一致。普通股已发行股本（不包括库存股）仍为720,000,000股，总数与上月底相同。公司确认截至报告期末符合香港联合交易所有限公司对上市公司公众持股量的相关要求。\n报告称，当月无任何股份期权或股权激励计划变动，也不存在可换股票据及其他与公司股份发行相关的协议签署或安排。公告由执行董事张宏丽签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651584492","title":"【券商聚焦】光大证券：议优先布局经营稳健、业绩扎实或者股息类中药标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2651584492","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651584492?lang=zh_cn&edition=full","pubTime":"2026-07-16 08:54","pubTimestamp":1784163265,"startTime":"0","endTime":"0","summary":"金吾财讯 | 光大证券研究指，近期，中药板块持续上涨，主要受到市场避险、政策利好、业绩催化和估值底部等多重因素共同推动，中期配置价值显著，后市偏乐观。建议优先布局经营稳健、业绩扎实或者高股息类中药标的。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985990","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1564","BK0188","BK1219","BK4585","03320","BK0276","06178","01643","BK1191","BK1515","BK0183","03613","BK0012","02273","BK1197","BK1606","BK1570","00570","02161","BK1521","02877","VIG","BK4588","KCE","BK0028","601788","00874","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191339150","title":"现代中药集团更新6月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1191339150","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191339150?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:43","pubTimestamp":1782985398,"startTime":"0","endTime":"0","summary":"现代中药集团有限公司于2026年7月2日公布2026年6月股份变动月报表。报告期为当月1日至30日。根据公告，现代中药集团本月的法定股本与注册股本均未发生变更。截至2026年6月30日，公司法定/注册股本为10,000,000,000股普通股，每股面值为0.01港元，合计注册股本为100,000,000港元。期末已发行股份总数与上月相同，维持在720,000,000股，库藏股数量为零。公告同时显示，截至2026年6月30日，现代中药集团已符合香港联交所主板上市规则下的公众持股量要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174255557","title":"现代中药集团2026年5月无新增发行或股份变动，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1174255557","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174255557?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:53","pubTimestamp":1780304031,"startTime":"0","endTime":"0","summary":"现代中药集团于2026年6月1日发布截至2026年5月31日的证券变动月报表。公告显示，公司法定注册股本为100,000,000港元，对应普通股10,000,000,000股，每股面值0.01港元；报告期末与上月底相比并无变动。\n本月末已发行股份总数为720,000,000股，较上月底保持不变，库藏股份数量依旧为零。报告期内公司未进行任何新增发行、购回或注销股份，也无新增期权计划或任何股权激励事项。公司确认，截至2026年5月末，已符合法定的最低公众持股量要求，股本结构维持稳定。\n该公告由执行董事张宏丽签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518576871","title":"现代中药集团盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518576871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518576871?lang=zh_cn&edition=full","pubTime":"2025-03-11 13:05","pubTimestamp":1741669531,"startTime":"0","endTime":"0","summary":"2025年03月11日下午盘13时05分，现代中药集团股票出现异动，股价快速跳水5.00%。截至发稿，该股报0.380港元/股，成交量101.4万股，换手率0.17%，振幅8.75%。现代中药集团股票所在的中医药行业中，整体涨幅为0.06%。其相关个股中，福森药业、位元堂、白云山涨幅较大，振幅较大的相关个股有现代中药集团、中国智能健康、白云山，振幅分别为7.50%、2.92%、2.84%。现代中药集团公司简介：现代中药集团有限公司是一家主要生产中成药的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031113053198a35e61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031113053198a35e61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01643","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518216933","title":"现代中药集团(01643)：谢婉婷已获委任为联席公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2518216933","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518216933?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:53","pubTimestamp":1741596821,"startTime":"0","endTime":"0","summary":"智通财经APP讯，现代中药集团(01643)发布公告，陈梓烯(前称陈缊凌)因工作变动已提交辞呈，自本公告日期起，辞任(i)公司联席公司秘书;(ii)香港联合交易所有限公司(联交所)证券上市规则(上市规则)第3.05条规定的公司授权代表;及(iii)公司在香港接收法律程序文件及通知书的代表(接收法律程序文件的代表)。自本公告日期起，谢婉婷已获委任为：(i)公司联席公司秘书;(ii)上市规则第3.05条规定的公司授权代表;及(iii)接收法律程序文件的代表。贾艳茹将继续担任公司另一名联席公司秘书。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","01643","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517689124","title":"现代中药集团盘中异动 下午盘股价大涨6.33%报0.420港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517689124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517689124?lang=zh_cn&edition=full","pubTime":"2025-03-07 13:33","pubTimestamp":1741325622,"startTime":"0","endTime":"0","summary":"2025年03月07日下午盘13时33分，现代中药集团股票出现波动，股价大幅上涨6.33%。截至发稿，该股报0.420港元/股，成交量77.1万股，换手率0.13%，振幅8.86%。资金方面，该股资金流入18.2325万港元，流出8.145万港元。现代中药集团股票所在的中医药行业中，整体涨幅为0.04%。其相关个股中，福森药业、中国中药、同仁堂国药涨幅较大，振幅较大的相关个股有福森药业、现代中药集团、中国中药，振幅分别为10.20%、3.80%、3.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307133342a2638a39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307133342a2638a39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01643","BK1606"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cdysjdyy.com","stockEarnings":[{"period":"1week","weight":0.0909},{"period":"1month","weight":-0.3793},{"period":"3month","weight":-0.5663},{"period":"6month","weight":-0.8842},{"period":"1year","weight":-0.5068},{"period":"ytd","weight":-0.2941}],"compareEarnings":[{"period":"1week","weight":0.0451},{"period":"1month","weight":0.0098},{"period":"3month","weight":-0.0469},{"period":"6month","weight":-0.0735},{"period":"1year","weight":-0.0683},{"period":"ytd","weight":-0.0461}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"现代中药集团有限公司是一家主要生产中成药的投资控股公司。该公司主要提供中老年人士使用的非处方药及处方药。该公司的主要产品为补肾填精丸、气血双补丸、山玫胶囊、金匮肾气丸、心安胶囊、加味逍遥丸、护肝片、加味藿香正气丸、舒肝和胃丸及清瘟解毒丸。该公司的主要产品目标疗效为治疗及舒缓补气补血类、心脑血管类、消化系统类、妇科类之不适症状。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.079689},{"month":2,"riseRate":0.333333,"avgChangeRate":0.093432},{"month":3,"riseRate":0.666667,"avgChangeRate":0.114029},{"month":4,"riseRate":0.5,"avgChangeRate":0.021083},{"month":5,"riseRate":0.5,"avgChangeRate":-0.008827},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.069521},{"month":7,"riseRate":0.166667,"avgChangeRate":0.026277},{"month":8,"riseRate":0.5,"avgChangeRate":-0.054014},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.03146},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.112645},{"month":11,"riseRate":0.5,"avgChangeRate":0.069484},{"month":12,"riseRate":0.4,"avgChangeRate":-0.008608}],"exchange":"SEHK","name":"现代中药集团","nameEN":"MODERN CHI MED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"现代中药集团(01643)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供现代中药集团(01643)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"现代中药集团,01643,现代中药集团股票,现代中药集团股票老虎,现代中药集团股票老虎国际,现代中药集团行情,现代中药集团股票行情,现代中药集团股价,现代中药集团股市,现代中药集团股票价格,现代中药集团股票交易,现代中药集团股票购买,现代中药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"现代中药集团(01643)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供现代中药集团(01643)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}